课题基金 / 基金详情

Inhibition of haemostasis as a novel host-directed therapy for tuberculosis

Inhibition of haemostasis as a novel host-directed therapy for tuberculosis
抑制止血作为结核病的新型宿主导向疗法
批准号:
nhmrc : 1099912
负责人:
Dr Stefan Oehlers
金额:
$36.47万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2016
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2016-01-01 至 2019-12-31

项目摘要

项目成果

Dr Stefan Oehlers的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Mycobacterium tuberculosis-induced vasculopathy is an important cause of stroke worldwide, and stroke is a common (~20%) complication of tuberculous meningitis, the most dangerous presentation of tuberculosis. Blood clotting may also speed the growth tuberculosis in the body further worsening the situation. We will use zebrafish find out if clotting can be targeted to slow the growth of mycobacteria and then translate our findings to a mouse model of pulmonary tuberculosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibition of haemostasis as a novel host-directed therapy for tuberculosis
  • 批准号:
    nhmrc : GNT1099912
  • 项目类别:
    Project Grants
  • 资助金额:
    $52.85万
  • 财政年份:
    2016
  • 负责人:
    Dr Stefan Oehlers
  • 依托单位:
Mycobacterial control of the establishment and outcome of infection
  • 批准号:
    nhmrc : GNT1053407
  • 项目类别:
    Early Career Fellowships
  • 资助金额:
    $20.8万
  • 财政年份:
    2013
  • 负责人:
    Dr Stefan Oehlers
  • 依托单位:
Identification of Mycobacterial Gene Products that Modulate Host Inflammation
  • 批准号:
    nhmrc : 1053407
  • 项目类别:
    Early Career Fellowships
  • 资助金额:
    $22.0万
  • 财政年份:
    2013
  • 负责人:
    Dr Stefan Oehlers
  • 依托单位:
海外基金